In Re Omeprazole Patent Litigation

Federal Circuit

In Re Omeprazole Patent Litigation

Procedural entryThis page is a short order in In Re Omeprazole Patent Litigation. Read the opinion of the Court — 536 F.3d 1361 →

Court of Appeals for the Federal Circuit·Decided October 15, 2010·No. 2010-1414·Unpublished

Opinion

NOTE: ThiS order is n0nprecedentia1. United States Court of Appeals for the FederaI Circuit IN RE OMEPRAZOLE PATENT LITIGATION ASTRAZENECA AB, AKTIEBOLAGET HASSLE, KBI-E, INC., KBI, INC., AND ASTRAZENECArLP, Plaintiffs-Appellees, V. MYLAN LABORATORIES INC. (N0w KNOWN As MYLAN INC.), MYLAN PHARMACEUTICALS INC., LABORATORIOS DR. ESTEVE, S.A., AND ESTEVE QUIMICA, S.A., Defendan,ts-Appellants. 2010-1414 Appeal from the United States DiStrict C0urt for the S0uthern District of NeW Y0rk in case n0S. 00-CV-6749, 03-CV-6057, M-21-81, and MDL n0. 1291, Judge Barbara S. J0nes. ON MOTION ORDER

ASTRAZENECA AB V. MYLAN LABS 2 AstraZeneca AB, et al. move for a 30 day extension of tirne, until N0vember 15, 201U, to file their response brief and for a 4-day extension of time, until Dece1nber 3, 2010, for Mylan Laboratories, Inc., et al. to file their reply brief Up0n consideration thereof I'r ls ORnERED THAT: The motion is granted FoR THE CoURT UCT 1 5 2010 /s/ J an Horbal3[ Date J an H0rbaly Clerk _ cc: Errol B. Taylor, Esq. James H. Wallace, Jr., Esq. lLED 521 “~’ve2zrfe;.rast§:°" OCT 1 5 2010 .lAN HORBALY CLERK

Free access — add to your briefcase to read the full text and ask questions with AI

NOTE: ThiS order is n0nprecedentia1. United States Court of Appeals for the FederaI Circuit IN RE OMEPRAZOLE PATENT LITIGATION ASTRAZENECA AB, AKTIEBOLAGET HASSLE, KBI-E, INC., KBI, INC., AND ASTRAZENECArLP, Plaintiffs-Appellees, V. MYLAN LABORATORIES INC. (N0w KNOWN As MYLAN INC.), MYLAN PHARMACEUTICALS INC., LABORATORIOS DR. ESTEVE, S.A., AND ESTEVE QUIMICA, S.A., Defendan,ts-Appellants. 2010-1414 Appeal from the United States DiStrict C0urt for the S0uthern District of NeW Y0rk in case n0S. 00-CV-6749, 03-CV-6057, M-21-81, and MDL n0. 1291, Judge Barbara S. J0nes. ON MOTION ORDER

ASTRAZENECA AB V. MYLAN LABS 2 AstraZeneca AB, et al. move for a 30 day extension of tirne, until N0vember 15, 201U, to file their response brief and for a 4-day extension of time, until Dece1nber 3, 2010, for Mylan Laboratories, Inc., et al. to file their reply brief Up0n consideration thereof I'r ls ORnERED THAT: The motion is granted FoR THE CoURT UCT 1 5 2010 /s/ J an Horbal3[ Date J an H0rbaly Clerk _ cc: Errol B. Taylor, Esq. James H. Wallace, Jr., Esq. lLED 521 “~’ve2zrfe;.rast§:°" OCT 1 5 2010 .lAN HORBALY CLERK

In Re Omeprazole Patent Litigation, (Fed. Cir. 2010).

Pincite

In Re Omeprazole Patent Litigation (In Re Omeprazole Patent Litigation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.